223 related articles for article (PubMed ID: 28528298)
1. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease.
Deshwal S; Di Sante M; Di Lisa F; Kaludercic N
Curr Opin Pharmacol; 2017 Apr; 33():64-69. PubMed ID: 28528298
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders.
Srivastava P; Sudevan ST; Thennavan A; Mathew B; Kanthlal SK
CNS Neurol Disord Drug Targets; 2024; 23(3):331-341. PubMed ID: 36872357
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor design for monoamine oxidases.
Ramsay RR
Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury.
Bianchi P; Kunduzova O; Masini E; Cambon C; Bani D; Raimondi L; Seguelas MH; Nistri S; Colucci W; Leducq N; Parini A
Circulation; 2005 Nov; 112(21):3297-305. PubMed ID: 16286591
[TBL] [Abstract][Full Text] [Related]
5. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
Duarte P; Cuadrado A; León R
Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidases as sources of oxidants in the heart.
Kaludercic N; Mialet-Perez J; Paolocci N; Parini A; Di Lisa F
J Mol Cell Cardiol; 2014 Aug; 73():34-42. PubMed ID: 24412580
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inactivation: from pathophysiology to therapeutics.
Bortolato M; Chen K; Shih JC
Adv Drug Deliv Rev; 2008; 60(13-14):1527-33. PubMed ID: 18652859
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.
Kaludercic N; Carpi A; Menabò R; Di Lisa F; Paolocci N
Biochim Biophys Acta; 2011 Jul; 1813(7):1323-32. PubMed ID: 20869994
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury.
Costiniti V; Spera I; Menabò R; Palmieri EM; Menga A; Scarcia P; Porcelli V; Gissi R; Castegna A; Canton M
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3050-3059. PubMed ID: 29953926
[TBL] [Abstract][Full Text] [Related]
10. Drugs related to monoamine oxidase activity.
Fišar Z
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
[TBL] [Abstract][Full Text] [Related]
11. Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.
Aljanabi R; Alsous L; Sabbah DA; Gul HI; Gul M; Bardaweel SK
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641563
[TBL] [Abstract][Full Text] [Related]
12. [Monoamine oxidase as a target for drug action].
Drozak J; Kozłowski M
Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.
Kaludercic N; Carpi A; Nagayama T; Sivakumaran V; Zhu G; Lai EW; Bedja D; De Mario A; Chen K; Gabrielson KL; Lindsey ML; Pacak K; Takimoto E; Shih JC; Kass DA; Di Lisa F; Paolocci N
Antioxid Redox Signal; 2014 Jan; 20(2):267-80. PubMed ID: 23581564
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes.
Deshwal S; Forkink M; Hu CH; Buonincontri G; Antonucci S; Di Sante M; Murphy MP; Paolocci N; Mochly-Rosen D; Krieg T; Di Lisa F; Kaludercic N
Cell Death Differ; 2018 Sep; 25(9):1671-1685. PubMed ID: 29459772
[TBL] [Abstract][Full Text] [Related]
15. Monoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart Surgery.
Duicu OM; Lighezan R; Sturza A; Ceausu RA; Borza C; Vaduva A; Noveanu L; Gaspar M; Ionac A; Feier H; Muntean DM; Mornos C
Biomed Res Int; 2015; 2015():515437. PubMed ID: 26101773
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidases in development.
Wang CC; Billett E; Borchert A; Kuhn H; Ufer C
Cell Mol Life Sci; 2013 Feb; 70(4):599-630. PubMed ID: 22782111
[TBL] [Abstract][Full Text] [Related]
17. The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity.
Antonucci S; Di Sante M; Tonolo F; Pontarollo L; Scalcon V; Alanova P; Menabò R; Carpi A; Bindoli A; Rigobello MP; Giorgio M; Kaludercic N; Di Lisa F
Antioxid Redox Signal; 2021 Mar; 34(7):531-550. PubMed ID: 32524823
[No Abstract] [Full Text] [Related]
18. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria.
Yoshino S; Hara A; Sakakibara H; Kawabata K; Tokumura A; Ishisaka A; Kawai Y; Terao J
Nutrition; 2011; 27(7-8):847-52. PubMed ID: 21371861
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes.
Sturza A; Duicu OM; Vaduva A; Dănilă MD; Noveanu L; Varró A; Muntean DM
Can J Physiol Pharmacol; 2015 Jul; 93(7):555-61. PubMed ID: 25996256
[TBL] [Abstract][Full Text] [Related]
20. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
Naoi M; Riederer P; Maruyama W
J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
